Ulti med Products

What Ulti med Products does

ulti med Products (Deutschland) GmbH is a privately held German specialty manufacturer of in-vitro diagnostic (IVD) rapid tests and drug screening products, headquartered in Ahrensburg near Hamburg. Founded and EN ISO 13485:2016 certified since 2000, the company develops, produces, and exports chromatographic immunoassay-based lateral-flow tests covering drug detection (the Drugnostic and Touch&Know product lines for substances such as amphetamines, cocaine, THC, MDMA, GHB, fentanyl), infectious disease screening (Influenza A/B, Strep A, SARS-CoV-2/Influenza/RSV combo), colorectal cancer screening (FOB test), and ovulation testing (hLH strips). A separate Touch&Know line detects explosive substances on the FBI threat list.

The company operates a dual B2B/B2C go-to-market model. B2B sales to hospitals, authorities, law enforcement, and addiction counseling centers are conducted by phone and email with bulk minimum order quantities of 1,000 units on selected SKUs. Direct-to-consumer sales occur through the proprietary ultimed.de e-commerce storefront and the Amazon.de marketplace. Net pricing is published with payment on 10-day terms, and domestic shipments achieve 90% two-day delivery. Customer-facing touchpoints include a website, Amazon listing, and active social channels (LinkedIn, Facebook, Instagram, Xing, X/Twitter). The company maintains localized German, English, and Belgian storefronts at ultimed.de, ultimed.org, and ultimed.be, indicating a DACH/Benelux commercial footprint.

Operationally, ulti med Products runs with 11-50 employees from a single Ahrensburg facility under managing director Matthias W. Engel. There are no disclosed funding rounds, acquisitions, partnerships, or external institutional investors. The company generates revenue through one-time unit sales of test kits across consumer and professional channels, with the Sicherheitskonzepte category offering customized workplace drug testing programs as a complementary managed offering.

Name

Ulti med Products

Legal name

ulti med Products (Deutschland) GmbH

Website

https://ultimed.de

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

ulti med Products (Deutschland) GmbH is a German specialty manufacturer of in-vitro diagnostic rapid tests and drug/substance screening products, ISO 13485 certified since 2000. It sells through e-commerce, Amazon, and direct B2B channels to healthcare providers, law enforcement, employers, and private consumers.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro industry

PRIMARYHLAHAOAK

Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics

SECONDARYHLAIADAO

Home Diagnostic & Self-Test OTC Kits

Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

SECONDARYCRADAMAK

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

SECONDARYHLAHAOAF

Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics

Keywords

• Rapid diagnostic tests
• In-vitro diagnostics
• Drug testing kits
• Lateral flow immunoassays
• Medical device manufacturing

Headquarters

HQ city

Ahrensburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Rapid Diagnostic Test Sales: Sale of in-vitro diagnostic rapid tests including drug tests, infectious disease tests (influenza, strep), and cancer screening tests (FOB). One-time purchase model for individual test kits.
2. Consumer Drug Test Products: Sale of drug rapid tests for home use, including Drugnostic multi-panel tests and Touch&Know substance detection kits. Sold directly to consumers via e-commerce and marketplace.
3. B2B Professional Diagnostic Tests: Sale of professional-use rapid diagnostic tests to healthcare providers, hospitals, authorities, and addiction counseling centers. Includes bulk ordering with minimum quantities.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Ulti med Products manufactures and distributes rapid in-vitro diagnostic test kits used for drug detection, infectious disease screening (COVID-19, influenza, RSV, strep A), fecal occult blood testing, ovulation/pregnancy testing, and substance/explosive detection. The company develops and produces its own lateral flow immunoassay-based products under proprietary technology platforms such as Touch&Know and fluorecare®, and serves both professional buyers (healthcare providers, law enforcement, counseling centers, employers) and end consumers via home-test product lines.

Product overview

Ulti med Products is an expert in in-vitro diagnostics and drug testing, headquartered in Ahrensburg, Germany. The company operates primarily as a product-based business organized around five product categories: (1) Schnelltests (professional rapid tests), (2) Heimtests (home/self-use tests), (3) COVID-19, Influenza A/B & RSV tests, (4) Sicherheitskonzepte (safety/testing programs), and (5) Zubehör (accessories). Key branded product lines include the DRUGNOSTIC rapid drug test family — covering multi-drug cassettes, urine dip tests, oral fluid cup tests, and single-parameter pipette tests — and the Touch&Know line of field tests, which encompasses both drug/substance detection tests (GHB/K.O. Tropfen, Ecstasy/MDMA, Fentanyl, Methylphenidat, GBL, Mecke Reagenz) and explosive substance tests (ammonium nitrate, TATP/peroxide, cyanide, acetic anhydride). On the medical diagnostics side, the portfolio includes the fluorecare® SARS-CoV-2 & Influenza A/B & RSV Combo Test for simultaneous detection of respiratory pathogens, the Influenza A+B Antigentest, the Strep A Schnelltest, the FOB Test for colorectal cancer early screening, and hLH ovulation test strips. All products are distributed under the ulti med Products (Deutschland) GmbH brand.

Differentiator

Problem solved

Functional benefit

Brands

• DRUGNOSTIC: Drug rapid test brand for detection of amphetamine, cocaine, methamphetamine, opiates, marijuana, and ecstasy-MDMA
• Touch&Know
• fluorecare
• FOB Test

Products and services

• COVID-19, Influenza A/B & RSV Combo Test (fluorecare®) Combined rapid antigen test for SARS-CoV-2, influenza A/B, and RSV intended for professional point-of-care use.
• DRUGNOSTIC – Drogenschnelltest Rapid drug test cassette intended for professional use by authorities, clinics, and law enforcement for point-of-care drug screening in urine.
• Einzel-Drogen-Pipettiertests Single-analyte pipetted urine drug rapid tests for professional use.
• Multi-Drogen-Pipettiertest Multi-analyte pipetted urine drug rapid test cassettes for simultaneous detection of multiple substances.
• Multi Tauchtest Urin Multi-analyte dip-style urine drug rapid test for professional point-of-care screening.
• Multi-Bechertest „Secure 5" Multi-drug urine cup test (Secure 5) for professional use, providing on-site drug screening with integrated sample collection.
• Oral-Fluid Saliva Cup S2 Saliva-based drug screening cup for non-invasive oral-fluid drug testing in professional settings.
• FOB Test (Darmkrebs Früherkennung) Fecal occult blood rapid test for early colorectal cancer screening, distributed to pharmacies and end users.
• Strep A Schnelltest Rapid antigen test for the detection of Group A Streptococcus in throat samples, for professional point-of-care use.
• hLH Teststreifen Rapid test strip for detecting human luteinizing hormone (hLH) to support fertility tracking and ovulation prediction in consumers.
• Touch&Know – Drogen- und Substanztests Proprietary Touch&Know product line for drug and substance detection, marketed for use by professionals and end consumers.
• Touch&Know – Explosivstofftests Proprietary Touch&Know product line for explosive substance detection, intended for security and law-enforcement buyers.
• Sicherheitskonzepte (Custom Safety Concepts) Bundled safety solutions combining drug-testing products, training materials, and program design for workplaces, schools, and organizations.

Quantifiable outcome

• 90% of domestic German shipments arrive within 2 days
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• BTNX Inc. Canadian manufacturer of rapid lateral-flow diagnostic tests including multi-panel drug tests. Comparable product format and B2B/B2C go-to-market across workplace, clinical, and at-home channels.
• nal von minden GmbH: German manufacturer of drug rapid tests (urine, saliva, surface) and other IVD reagents. Directly comparable product portfolio and similar SME profile serving professional and consumer channels in Europe.
• Drägerwerk AG & Co. KGaA: German safety/medical technology company with the DrugTest 5000 and DrugCheck systems used by German police and workplaces. Competes head-to-head in law enforcement and workplace drug detection.
• Premier Biotech, Inc. U.S. drug test manufacturer offering urine, saliva, and surface drug screens with similar multi-panel product formats. Comparable in distribution through B2B channels and minimum-order-quantity models.
• OraSure Technologies, Inc. U.S. company specializing in oral fluid (saliva) sample collection and drug testing devices, including Intercept. Comparable on oral-fluid drug testing and workplace/law-enforcement use cases.
• Securetec Detektions-Systeme AG: Germany-based specialist in on-site drug and substance detection systems, including lateral-flow drug tests. Closest comparable in geography, product format, and customer base (law enforcement, workplace).
• Acon Laboratories, Inc. U.S. manufacturer of lateral-flow rapid diagnostic tests (drugs, infectious disease, fertility). Highly comparable technology platform and multi-category IVD product strategy.

Emerging players

• SD Biosensor, Inc. South Korea-based rapid IVD manufacturer with strong presence in infectious disease and emerging market drug testing. Increasingly competitive on price in European tenders and consumer marketplaces.

Broad incumbents

• Abbott Rapid Diagnostics: Global IVD incumbent (formerly Alere Toxicology) offering drug testing, infectious disease, and consumer diagnostics. Overlaps with Ulti med across multiple product categories but at significantly larger scale.
• QuidelOrtho Corporation: Broad rapid diagnostics player (Sofia platform, Triage) covering infectious disease and toxicology. Larger portfolio competitor in clinical and point-of-care channels in Europe and globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ultimedproducts
• Facebookfacebook.com/ultimedproducts
• LinkedInlinkedin.com/company/27143849
• Instagraminstagram.com/ultimedproducts

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ulti med Products